Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

Live attenuated E. coli K1 vaccine for neonatal meningitis

August 1, 2024 4:16 PM UTC

Pre-conception vaccination with a live attenuated clinical strain of Escherichia coli K1 lacking the virulence factor E. coli aroA, an enzyme involved in aromatic amino acid biosynthesis and iron capture, could help prevent neonatal meningitis by inducing maternal polyclonal antibodies that are passed to offspring.

In female mice, intraperitoneal injection with E. coli K1 lacking aroA reduced bacterial virulence 10- to 1000-fold compared with injection of wild-type E. coli K1 and non-K1 meningitis strains. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article